X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs PANACEA BIOTECH - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD PANACEA BIOTECH STRIDES SHASUN LTD/
PANACEA BIOTECH
 
P/E (TTM) x 14.1 80.9 17.5% View Chart
P/BV x 1.9 1.8 106.4% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 STRIDES SHASUN LTD   PANACEA BIOTECH
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-16
PANACEA BIOTECH
Mar-14
STRIDES SHASUN LTD/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,413149 949.9%   
Low Rs84882 1,030.4%   
Sales per share (Unadj.) Rs353.384.1 419.8%  
Earnings per share (Unadj.) Rs23.4-18.3 -127.7%  
Cash flow per share (Unadj.) Rs41.0-6.7 -611.9%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs320.483.7 382.8%  
Shares outstanding (eoy) m89.3561.25 145.9%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x3.21.4 233.1%   
Avg P/E ratio x48.3-6.3 -766.1%  
P/CF ratio (eoy) x27.6-17.2 -159.9%  
Price / Book Value ratio x3.51.4 255.6%  
Dividend payout %21.40-   
Avg Mkt Cap Rs m100,9887,074 1,427.5%   
No. of employees `0004.72.8 170.5%   
Total wages/salary Rs m4,9881,449 344.2%   
Avg. sales/employee Rs Th6,730.01,874.1 359.1%   
Avg. wages/employee Rs Th1,063.6527.0 201.8%   
Avg. net profit/employee Rs Th445.5-407.7 -109.3%   
INCOME DATA
Net Sales Rs m31,5645,154 612.4%  
Other income Rs m1,212100 1,214.6%   
Total revenues Rs m32,7765,254 623.9%   
Gross profit Rs m5,213-766 -680.3%  
Depreciation Rs m1,573711 221.2%   
Interest Rs m1,8031,503 120.0%   
Profit before tax Rs m3,049-2,881 -105.9%   
Minority Interest Rs m12711 1,172.2%   
Prior Period Items Rs m-27-6 471.9%   
Extraordinary Inc (Exp) Rs m-3711,771 -20.9%   
Tax Rs m68917 4,098.5%   
Profit after tax Rs m2,089-1,121 -186.3%  
Gross profit margin %16.5-14.9 -111.1%  
Effective tax rate %22.6-0.6 -3,871.8%   
Net profit margin %6.6-21.8 -30.4%  
BALANCE SHEET DATA
Current assets Rs m35,9493,810 943.5%   
Current liabilities Rs m19,4028,365 231.9%   
Net working cap to sales %52.4-88.4 -59.3%  
Current ratio x1.90.5 406.8%  
Inventory Days Days71156 45.5%  
Debtors Days Days12767 188.6%  
Net fixed assets Rs m34,47814,480 238.1%   
Share capital Rs m89461 1,457.6%   
"Free" reserves Rs m22,601903 2,502.5%   
Net worth Rs m28,6325,127 558.4%   
Long term debt Rs m27,4555,832 470.8%   
Total assets Rs m76,59119,433 394.1%  
Interest coverage x2.7-0.9 -293.6%   
Debt to equity ratio x1.01.1 84.3%  
Sales to assets ratio x0.40.3 155.4%   
Return on assets %5.12.0 258.7%  
Return on equity %7.3-21.9 -33.4%  
Return on capital %8.23.6 224.6%  
Exports to sales %48.124.5 196.3%   
Imports to sales %14.510.2 142.0%   
Exports (fob) Rs m15,1921,264 1,202.1%   
Imports (cif) Rs m4,565525 869.8%   
Fx inflow Rs m16,6121,539 1,079.3%   
Fx outflow Rs m5,292942 561.8%   
Net fx Rs m11,320597 1,895.5%   
CASH FLOW
From Operations Rs m717599 119.6%  
From Investments Rs m-22,284-438 5,088.9%  
From Financial Activity Rs m29,488-303 -9,744.7%  
Net Cashflow Rs m8,073-141 -5,713.4%  

Share Holding

Indian Promoters % 27.7 74.5 37.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.8 0.6 6,300.0%  
FIIs % 8.6 1.3 661.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 23.6 109.7%  
Shareholders   56,241 10,259 548.2%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   NOVARTIS  ASTRAZENECA PHARMA  BIOCON LTD  IPCA LABS  JUBILANT LIFE SCIENCES  

Compare STRIDES SHASUN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Aug 17, 2017 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 5-YR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS